Please be aware that Mahajan Imaging & Labs will never request for your bank details or OTP for booking/registration purposes.

What is a PHENYL ALANINE NEONATAL SCREEN DRIED BLOOD SPOT?

The Phenylalanine Neonatal Screen (Dried Blood Spot) test is a newborn screening test performed shortly after birth to detect elevated levels of phenylalanine in the blood. High levels indicate phenylketonuria (PKU), a rare genetic disorder where the body cannot properly break down phenylalanine, leading to potential brain damage if untreated. This test is done to ensure early diagnosis, allowing timely dietary management and preventing long-term complications in affected infants.

Additional Information

Also known as/ Other names: Newborn Phenylalanine Screening, PKU Neonatal Screening Test, Phenylalanine Dried Blood Spot Test, Newborn Screening for Phenylketonuria (PKU)
Parameters: 1
Recommended for: M/F/Others
Sample Type: Blood
Patient Preparation: No prior preparation is needed
Reports: 3 days

FAQs

Why is this test important?

It helps diagnose PKU early, allowing dietary management to prevent brain damage, developmental delays, and other long-term complications.

Who should undergo this test?

All newborns are routinely screened for PKU as part of standard neonatal screening programs.

What happens if the test is positive?

A positive result suggests elevated phenylalanine levels, requiring confirmatory testing and immediate dietary intervention.

What does a negative result mean?

It indicates normal phenylalanine levels, ruling out phenylketonuria.

Is this test safe for infants?

Yes, it is safe, minimally invasive, and routinely performed worldwide.

Can medications affect the test results?

No, medications do not interfere with phenylalanine level detection in newborns.

What are the risks of not testing?

Without testing, PKU may remain undiagnosed, leading to irreversible brain damage and developmental issues.

Recommend more for you

Book Your Test
Text copied to clipboard
Dynamic badges will be added here